Rapid Micro Biosystems (RPID) Current Leases (2022 - 2026)
Rapid Micro Biosystems (RPID) reported Current Leases of $1.3 million for Q1 2026, up 6.88% on a YoY basis from $1.2 million in Q1 2025, and up 1.69% sequentially from $1.3 million in Q4 2025.
Rapid Micro Biosystems (RPID) Current Leases (2022 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 5 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 6.88% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 6.88% YoY), and the FY2025 full-year result was $1.3 million, up 6.92% from the prior year.
- Current Leases climbed to $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.3 million in Q1 2026 to a low of $635000.0 in Q1 2022.
- A 5-year average of $1.0 million and a median of $1.2 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 49.16% in 2024 and grew 6.88% in 2026, its largest moves.
- Tracing RPID's Current Leases over 5 years: stood at $766000.0 in 2022, then surged by 47.78% to $1.1 million in 2023, then advanced by 7.24% to $1.2 million in 2024, then advanced by 6.92% to $1.3 million in 2025, then increased by 1.69% to $1.3 million in 2026.
- Business Quant data shows RPID's Current Leases at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 841,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | 766,000.00 |
| Sep 30, 2022 | 747,000.00 |
| Jun 30, 2022 | 729,000.00 |
| Mar 31, 2022 | 635,000.00 |